26 March 2020 - Shares in ASX-listed tech provider MedAdvisor are up by almost 25%, after the company announced a 'Uber for pharmacies', allowing the likes of TerryWhite Chemmart and Amcal to deliver medications to patients during the COVID-19 crisis.

MedAdvisor chief executive Robert Read said his company's software will facilitate pharmacists' ability to claim their part of $25m in new federal government funding to support pharmacist delivery services.

“Fast-tracking the launch of MedAdvisor’s medication home delivery service is necessary to help reduce panic buying, relieve pressure on pharmacists, protect patients from unnecessary exposure, and provide access to critical medications," he said.

Read The Australian article